Key Market Segments:
By Technology
-
-
MRI-Based Breast Biopsy
-
Ultrasound-Based Breast Biopsy
-
Mammography-Based (Stereotactic) Breast Biopsy
-
CT-Based Breast Biopsy
-
Other Image-Based Breast Biopsy
-
By End-Use
-
-
Hospitals & Diagnostic Laboratories
-
Pharmaceutical & Biotechnology companies
-
Academic & Research Institutes
-
Request for Segment Customization as per your Business Requirement: Segment Customization Request
Regional Coverage:
North America
-
US
-
Canada
-
Mexico
Europe
-
Eastern Europe
-
Poland
-
Romania
-
Hungary
-
Turkey
-
Rest of Eastern Europe
-
-
Western Europe
-
Germany
-
France
-
UK
-
Italy
-
Spain
-
Netherlands
-
Switzerland
-
Austria
-
Rest of Western Europe
-
Asia Pacific
-
China
-
India
-
Japan
-
South Korea
-
Vietnam
-
Singapore
-
Australia
-
Rest of Asia Pacific
Middle East & Africa
-
Middle East
-
UAE
-
Egypt
-
Saudi Arabia
-
Qatar
-
Rest of Middle East
-
-
Africa
-
Nigeria
-
South Africa
-
Rest of Africa
-
Latin America
-
Brazil
-
Argentina
-
Colombia
-
Rest of Latin America
Request for Country Level Research Report: Country Level Customization Request
Available Customization
With the given market data, SNS Insider offers customization as per the company’s specific needs. The following customization options are available for the report:
-
Detailed Volume Analysis
-
Criss-Cross segment analysis (e.g. Product X Application)
-
Competitive Product Benchmarking
-
Geographic Analysis
-
Additional countries in any of the regions
-
Customized Data Representation
-
Detailed analysis and profiling of additional market players
Frequently Asked Questions
North America dominated the Breast Cancer Core Needle Biopsy Market in 2023.
The “Ultrasound-Based Breast Biopsy” segment dominated the Breast Cancer Core Needle Biopsy Market.
Ongoing advances in biopsy technology are fueling the use of core needle biopsy in the diagnosis of breast cancer.
The Breast Cancer Core Needle Biopsy Market was USD 809.40 million in 2023 and is expected to reach USD 1357.70 million by 2032.
The Breast Cancer Core Needle Biopsy Market is expected to grow at a CAGR of 5.93% from 2024-2032.